Acute Neuroendocrine Response to Intravenous Infusion of Diclofenac Sodium
NCT05188131
·
clinicaltrials.gov ↗
PHASE4
Phase
COMPLETED
Status
12
Enrollment
OTHER
Sponsor class
Conditions
Hypopituitarism
Interventions
DRUG:
Intravenous Infusion of Diclofenac Sodium
DRUG:
Intravenous Infusion of Placebo
Sponsor
A.O.U. Città della Salute e della Scienza